NovoPedics Raises $500K from Foundation Venture Capital Group

NovoPedics, a developer of an implantable meniscus replacement/regeneration medical device, raised up to $500k from Foundation Venture Capital Group.

The company intends to use the funding to develop its device.

NovoPedics’s Meniscofix™, its first product, uses a biodegradable polymer fiber-reinforced scaffold to restore mobility to patients suffering from severe meniscus knee injuries and prevent the long-term development of arthritis.
The company was founded by Charles Gatt and Dr. Michael Dunn.



Join the discussion